Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995–2012
暂无分享,去创建一个
W. Arap | A. Meisner | C. Wiggins | R. Hoffman | S. Zeliadt | M. Barry | Satyan K. Shah | Angela L W Meisner
[1] J. Goodwin,et al. Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials. , 2013, Journal of the National Cancer Institute.
[2] E. Feuer,et al. Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.
[3] Jeffrey P. Cowan,et al. PSA screening: determinants of primary-care physician practice patterns , 2011, Prostate Cancer and Prostatic Diseases.
[4] C. Gross,et al. Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. , 2012, Archives of internal medicine.
[5] B. Helfand,et al. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. , 2014, Urologic oncology.
[6] V. Master,et al. Recent Trends in Prostate Cancer Incidence by Age, Cancer Stage, and Grade, the United States, 2001–2007 , 2012, Prostate cancer.
[7] K. Cooney,et al. Prostate cancer in young men: an important clinical entity , 2014, Nature Reviews Urology.
[8] Lisa M. Schwartz,et al. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? , 2003, JAMA.
[9] D. Howard. Declines in prostate cancer incidence after changes in screening recommendations. , 2012, Archives of internal medicine.
[10] Peter C Albertsen,et al. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. , 2009, Journal of the National Cancer Institute.
[11] S. Eggener,et al. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] B. G. Blijenberg,et al. Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.
[13] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[14] David Chia,et al. Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.
[15] Jim C Hu,et al. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. , 2012, JAMA.
[16] A. Jha,et al. Trends in prostate-specific antigen testing from 1995 through 2004. , 2007, Archives of internal medicine.
[17] Curtis Mettlin,et al. Defining and updating the american cancer society guidelines for the cancer‐related checkup: Prostate and endometrial cancers , 1993, CA: a cancer journal for clinicians.
[18] Mohammad Hassan Murad,et al. Early detection of prostate cancer: AUA Guideline. , 2013, The Journal of urology.
[19] J. Cerhan,et al. Prostate Cancer Trends 1973-1995, SEER Program National Cancer Institute. , 1999 .
[20] Prostate-Specific Antigen ( PSA ) Best Practice Policy , 2013 .
[21] D. Ekwueme,et al. Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. , 2013, Health affairs.
[22] Dietary Protein and Weight Gain—Reply , 2012 .
[23] A. D'Amico,et al. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.
[24] L. Ponsky,et al. The impact of recent screening recommendations on prostate cancer screening in a large health care system. , 2013, The Journal of urology.
[25] Michael R Hamblin,et al. CA : A Cancer Journal for Clinicians , 2011 .
[26] H. Comber,et al. Trends in prostate specific antigen testing in Ireland: lessons from a country without guidelines , 2010, Irish journal of medical science.
[27] R. Coates,et al. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. , 2004, Preventive medicine.
[28] A. Evans,et al. Impact of the U.S. Preventive Services Task Force recommendations against prostate specific antigen screening on prostate biopsy and cancer detection rates. , 2015, The Journal of urology.
[29] E. Messing,et al. Prostate‐specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system , 2012, BJU international.
[30] C. Pollack,et al. Primary care providers' response to the US Preventive Services Task Force draft recommendations on screening for prostate cancer. , 2012, Archives of internal medicine.
[31] G. Murphy,et al. American Cancer Society guideline for the early detection of prostate cancer: Update 1997 , 1997, CA: a cancer journal for clinicians.